Newsroom
Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs
Guardant Health, Pangaea Biotech, the Dr. Rosell Oncology Institute and MedSIR Announce a Strategic Collaboration to Study Liquid Biopsy in Spain
DiaCarta and Pangaea Biotech Join Forces to Launch Non-Invasive Tests to Detect Genetic Mutations in Blood from Cancer Patients
More Articles...
- Expert researchers from Pangaea Biotech, co-authors of results presented at AACR 2016
- Pangaea Biotech investigators, co-authors of presentations at ELCC 2016
- Sagrat Cor University Hospital, Pangaea Biotech S.L. and the Dr. Rosell Oncology Institute join forces to provide personalized cancer treatment
- Researchers at Pangaea Biotech (PB) warn that chemotherapy may contribute to development of resistance to anti-cancer drugs
Follow us
